Restaurants
Build Your Comparison
Side-by-side financial analysisStock Comparison
VENU vs SBUX vs KO vs MCD vs KDP vs JPM
Revenue, margins, valuation, and 5-year total return — side by side.
Restaurants
Beverages - Non-Alcoholic
Restaurants
Beverages - Non-Alcoholic
Banks - Diversified
VENU vs SBUX vs KO vs MCD vs KDP vs JPM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||||
|---|---|---|---|---|---|---|
| Industry | Restaurants | Restaurants | Beverages - Non-Alcoholic | Restaurants | Beverages - Non-Alcoholic | Banks - Diversified |
| Market Cap | $146M | $117.43B | $355.61B | $202.36B | $43.08B | $896.00B |
| Revenue (TTM) | $15M | $37.70B | $49.28B | $27.45B | $16.94B | $280.33B |
| Net Income (TTM) | $-40M | $1.37B | $13.70B | $8.68B | $1.83B | $57.05B |
| Gross Margin | -6.4% | 20.6% | 61.7% | 57.4% | 53.8% | 60.0% |
| Operating Margin | -302.8% | 9.0% | 29.3% | 46.0% | 21.3% | 25.9% |
| Forward P/E | — | 43.1x | 25.3x | 21.9x | 13.9x | 14.4x |
| Total Debt | $107M | $26.61B | $45.49B | $54.81B | $16.14B | $942.38B |
| Cash & Equiv. | $41M | $3.22B | $10.27B | $774M | $1.03B | $343.34B |
VENU vs SBUX vs KO vs MCD vs KDP vs JPM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Nov 24 | Jun 26 | Return |
|---|---|---|---|
| Venu Holding Corpor… (VENU) | 100 | 31.7 | -68.3% |
| Starbucks Corporati… (SBUX) | 100 | 100.6 | +0.6% |
| The Coca-Cola Compa… (KO) | 100 | 128.9 | +28.9% |
| McDonald's Corporat… (MCD) | 100 | 96.2 | -3.8% |
| Keurig Dr Pepper In… (KDP) | 100 | 97.1 | -2.9% |
| JPMorgan Chase & Co. (JPM) | 100 | 128.4 | +28.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: VENU vs SBUX vs KO vs MCD vs KDP vs JPM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
VENU lags the leaders in this set but could rank higher in a more targeted comparison.
Among these 6 stocks, SBUX doesn't own a clear edge in any measured category.
KO doesn't hold a clear category lead here; it's more of a secondary option in this specific comparison.
MCD carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- Dividend streak 17 yrs, beta 0.06, yield 2.5%
- Lower volatility, beta 0.06, current ratio 0.95x
- Beta 0.06, yield 2.5%, current ratio 0.95x
- 31.6% margin vs VENU's -262.7%
KDP is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 8.2%, EPS growth 45.7%, 3Y rev CAGR 5.7%
- 8.2% revenue growth vs VENU's 0.4%
- 2.9% yield, 5-year raise streak, vs KO's 2.5%, (1 stock pays no dividend)
JPM ranks third and is worth considering specifically for long-term compounding and valuation efficiency.
- 465.8% 10Y total return vs KDP's 8.8%
- PEG 0.81 vs SBUX's 2.77
- Lower P/E (14.4x vs 21.9x), PEG 0.81 vs 1.61
- +21.8% vs VENU's -68.1%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 8.2% revenue growth vs VENU's 0.4% | |
| Value | Lower P/E (14.4x vs 21.9x), PEG 0.81 vs 1.61 | |
| Quality / Margins | 31.6% margin vs VENU's -262.7% | |
| Stability / Safety | Beta 0.06 vs VENU's 1.79 | |
| Dividends | 2.9% yield, 5-year raise streak, vs KO's 2.5%, (1 stock pays no dividend) | |
| Momentum (1Y) | +21.8% vs VENU's -68.1% | |
| Efficiency (ROA) | 14.5% ROA vs VENU's -11.5%, ROIC 18.7% vs -20.7% |
VENU vs SBUX vs KO vs MCD vs KDP vs JPM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
VENU vs SBUX vs KO vs MCD vs KDP vs JPM — Financial Metrics
Side-by-side numbers across 6 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
KDP leads in 1 of 6 categories
MCD leads 1 • JPM leads 1 • KO leads 1 • VENU leads 0 • SBUX leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — KO and MCD each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM is the larger business by revenue, generating $280.3B annually — 18463.9x VENU's $15M. MCD is the more profitable business, keeping 31.6% of every revenue dollar as net income compared to VENU's -2.6%. On growth, KO holds the edge at +12.1% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||||
|---|---|---|---|---|---|---|
| RevenueTrailing 12 months | $15M | $37.7B | $49.3B | $27.4B | $16.9B | $280.3B |
| EBITDAEarnings before interest/tax | -$39M | $5.1B | $15.5B | $14.8B | $3.9B | $81.4B |
| Net IncomeAfter-tax profit | -$40M | $1.4B | $13.7B | $8.7B | $1.8B | $57.0B |
| Free Cash FlowCash after capex | -$177M | $2.3B | $12.6B | $7.0B | $1.6B | $100.9B |
| Gross MarginGross profit ÷ Revenue | -6.4% | +20.6% | +61.7% | +57.4% | +53.8% | +60.0% |
| Operating MarginEBIT ÷ Revenue | -3.0% | +9.0% | +29.3% | +46.0% | +21.3% | +25.9% |
| Net MarginNet income ÷ Revenue | -2.6% | +3.6% | +27.8% | +31.6% | +10.8% | +20.4% |
| FCF MarginFCF ÷ Revenue | -11.7% | +6.2% | +25.5% | +25.6% | +9.3% | +36.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | +11.5% | +5.4% | +12.1% | +9.4% | +9.4% | — |
| EPS Growth (YoY)Latest quarter vs prior year | +39.6% | -62.3% | +18.2% | +6.9% | -47.4% | +16.0% |
Valuation Metrics
KDP leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 16.0x trailing earnings, JPM trades at a 75% valuation discount to SBUX's 63.2x P/E. Adjusting for growth (PEG ratio), JPM offers better value at 0.90x vs SBUX's 4.06x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||||
|---|---|---|---|---|---|---|
| Market CapShares × price | $146M | $117.4B | $355.6B | $202.4B | $43.1B | $896.0B |
| Enterprise ValueMkt cap + debt − cash | $212M | $140.8B | $390.8B | $256.4B | $58.2B | $1.50T |
| Trailing P/EPrice ÷ TTM EPS | -3.11x | 63.21x | 27.18x | 23.83x | 20.73x | 16.00x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 43.10x | 25.27x | 21.92x | 13.88x | 14.40x |
| PEG RatioP/E ÷ EPS growth rate | — | 4.06x | 2.43x | 1.75x | 1.98x | 0.90x |
| EV / EBITDAEnterprise value multiple | — | 26.75x | 26.39x | 17.62x | 13.22x | 18.36x |
| Price / SalesMarket cap ÷ Revenue | 8.17x | 3.16x | 7.42x | 7.53x | 2.59x | 3.20x |
| Price / BookPrice ÷ Book value/share | 0.63x | — | 10.40x | — | 1.69x | 2.47x |
| Price / FCFMarket cap ÷ FCF | — | 48.09x | 67.15x | 28.16x | 28.63x | 8.88x |
Profitability & Efficiency
MCD leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
KO delivers a 41.1% return on equity — every $100 of shareholder capital generates $41 in annual profit, vs $-19 for VENU. VENU carries lower financial leverage with a 0.54x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), KO scores 7/9 vs SBUX's 4/9, reflecting strong financial health.
| Metric | ||||||
|---|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -18.7% | — | +41.1% | — | +7.0% | +15.9% |
| ROA (TTM)Return on assets | -11.5% | +4.2% | +13.1% | +14.5% | +3.1% | +1.3% |
| ROICReturn on invested capital | -20.7% | +17.7% | +15.8% | +18.7% | +6.7% | +4.5% |
| ROCEReturn on capital employed | -22.7% | +16.2% | +17.3% | +23.3% | +7.9% | +8.9% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 4 | 7 | 7 | 7 | 5 |
| Debt / EquityFinancial leverage | 0.54x | — | 1.33x | — | 0.63x | 2.60x |
| Net DebtTotal debt minus cash | $66M | $23.4B | $35.2B | $54.0B | $15.1B | $599.0B |
| Cash & Equiv.Liquid assets | $41M | $3.2B | $10.3B | $774M | $1.0B | $343.3B |
| Total DebtShort + long-term debt | $107M | $26.6B | $45.5B | $54.8B | $16.1B | $942.4B |
| Interest CoverageEBIT ÷ Interest expense | -4.98x | 6.03x | 10.70x | 7.92x | 3.68x | 0.74x |
Total Returns (Dividends Reinvested)
JPM leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in JPM five years ago would be worth $21,820 today (with dividends reinvested), compared to $3,379 for VENU. Over the past 12 months, JPM leads with a +21.8% total return vs VENU's -68.1%. The 3-year compound annual growth rate (CAGR) favors JPM at 33.6% vs VENU's -30.3% — a key indicator of consistent wealth creation.
| Metric | ||||||
|---|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -57.1% | +24.2% | +20.3% | -4.9% | +16.0% | -0.5% |
| 1-Year ReturnPast 12 months | -68.1% | +11.9% | +17.2% | -3.6% | -1.5% | +21.8% |
| 3-Year ReturnCumulative with dividends | -66.2% | +11.9% | +47.0% | +5.9% | +10.1% | +138.2% |
| 5-Year ReturnCumulative with dividends | -66.2% | +1.5% | +65.6% | +33.8% | +3.1% | +118.2% |
| 10-Year ReturnCumulative with dividends | -66.2% | +119.9% | +121.1% | +175.8% | +884.9% | +465.8% |
| CAGR (3Y)Annualised 3-year return | -30.3% | +3.8% | +13.7% | +1.9% | +3.3% | +33.6% |
Risk & Volatility
KO leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
KO is the less volatile stock with a -0.20 beta — it tends to amplify market swings less than VENU's 1.79 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. KO currently trades 98.3% from its 52-week high vs VENU's 18.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||||
|---|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.79x | 0.74x | -0.20x | 0.06x | 0.07x | 0.94x |
| 52-Week HighHighest price in past year | $18.17 | $108.86 | $84.04 | $341.75 | $35.94 | $337.25 |
| 52-Week LowLowest price in past year | $3.06 | $77.99 | $65.35 | $271.85 | $24.88 | $262.71 |
| % of 52W HighCurrent price vs 52-week peak | +18.8% | +94.7% | +98.3% | +83.3% | +88.2% | +95.1% |
| RSI (14)Momentum oscillator 0–100 | 48.2 | 56.5 | 60.6 | 53.8 | 66.4 | 59.1 |
| Avg Volume (50D)Average daily shares traded | 296K | 7.3M | 12.7M | 3.3M | 11.0M | 7.0M |
Analyst Outlook
Evenly matched — KO and KDP each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: SBUX as "Buy", KO as "Buy", MCD as "Buy", KDP as "Buy", JPM as "Buy". Consensus price targets imply 22.0% upside for MCD (target: $347) vs 4.2% for KO (target: $86). For income investors, KDP offers the higher dividend yield at 2.89% vs JPM's 1.86%.
| Metric | ||||||
|---|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | $108.50 | $86.13 | $347.33 | $33.14 | $339.75 |
| # AnalystsCovering analysts | — | 59 | 48 | 62 | 28 | 61 |
| Dividend YieldAnnual dividend ÷ price | — | +2.4% | +2.5% | +2.5% | +2.9% | +1.9% |
| Dividend StreakConsecutive years of raises | 1 | 16 | 56 | 17 | 5 | 15 |
| Dividend / ShareAnnual DPS | — | $2.43 | $2.04 | $7.14 | $0.92 | $5.95 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +0.2% | +1.0% | +0.0% | +3.9% |
KDP leads in 1 of 6 categories (Valuation Metrics). MCD leads in 1 (Profitability & Efficiency). 2 tied.
VENU vs SBUX vs KO vs MCD vs KDP vs JPM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is VENU or SBUX or KO or MCD or KDP or JPM a better buy right now?
For growth investors, Keurig Dr Pepper Inc.
(KDP) is the stronger pick with 8. 2% revenue growth year-over-year, versus 0. 4% for Venu Holding Corporation (VENU). JPMorgan Chase & Co. (JPM) offers the better valuation at 16. 0x trailing P/E (14. 4x forward), making it the more compelling value choice. Analysts rate Starbucks Corporation (SBUX) a "Buy" — based on 59 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — VENU or SBUX or KO or MCD or KDP or JPM?
On trailing P/E, JPMorgan Chase & Co.
(JPM) is the cheapest at 16. 0x versus Starbucks Corporation at 63. 2x. On forward P/E, Keurig Dr Pepper Inc. is actually cheaper at 13. 9x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: JPMorgan Chase & Co. wins at 0. 81x versus Starbucks Corporation's 2. 77x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — VENU or SBUX or KO or MCD or KDP or JPM?
Over the past 5 years, JPMorgan Chase & Co.
(JPM) delivered a total return of +118. 2%, compared to -66. 2% for Venu Holding Corporation (VENU). Over 10 years, the gap is even starker: KDP returned +884. 9% versus VENU's -66. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — VENU or SBUX or KO or MCD or KDP or JPM?
By beta (market sensitivity over 5 years), The Coca-Cola Company (KO) is the lower-risk stock at -0.
20β versus Venu Holding Corporation's 1. 79β — meaning VENU is approximately -994% more volatile than KO relative to the S&P 500. On balance sheet safety, Venu Holding Corporation (VENU) carries a lower debt/equity ratio of 54% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — VENU or SBUX or KO or MCD or KDP or JPM?
By revenue growth (latest reported year), Keurig Dr Pepper Inc.
(KDP) is pulling ahead at 8. 2% versus 0. 4% for Venu Holding Corporation (VENU). On earnings-per-share growth, the picture is similar: Keurig Dr Pepper Inc. grew EPS 45. 7% year-over-year, compared to -50. 8% for Starbucks Corporation. Over a 3-year CAGR, VENU leads at 27. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — VENU or SBUX or KO or MCD or KDP or JPM?
McDonald's Corporation (MCD) is the more profitable company, earning 31.
9% net margin versus -246. 4% for Venu Holding Corporation — meaning it keeps 31. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MCD leads at 46. 1% versus -296. 3% for VENU. At the gross margin level — before operating expenses — KO leads at 61. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is VENU or SBUX or KO or MCD or KDP or JPM more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, JPMorgan Chase & Co. (JPM) is the more undervalued stock at a PEG of 0. 81x versus Starbucks Corporation's 2. 77x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Keurig Dr Pepper Inc. (KDP) trades at 13. 9x forward P/E versus 43. 1x for Starbucks Corporation — 29. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MCD: 22. 0% to $347. 33.
08Which pays a better dividend — VENU or SBUX or KO or MCD or KDP or JPM?
In this comparison, KDP (2.
9% yield), MCD (2. 5% yield), KO (2. 5% yield), SBUX (2. 4% yield), JPM (1. 9% yield) pay a dividend. VENU does not pay a meaningful dividend and should not be held primarily for income.
09Is VENU or SBUX or KO or MCD or KDP or JPM better for a retirement portfolio?
For long-horizon retirement investors, Keurig Dr Pepper Inc.
(KDP) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 07), 2. 9% yield, +884. 9% 10Y return). Venu Holding Corporation (VENU) carries a higher beta of 1. 79 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (KDP: +884. 9%, VENU: -66. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between VENU and SBUX and KO and MCD and KDP and JPM?
These companies operate in different sectors (VENU (Consumer Cyclical) and SBUX (Consumer Cyclical) and KO (Consumer Defensive) and MCD (Consumer Cyclical) and KDP (Consumer Defensive) and JPM (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: VENU is a small-cap quality compounder stock; SBUX is a mid-cap quality compounder stock; KO is a large-cap quality compounder stock; MCD is a large-cap quality compounder stock; KDP is a mid-cap quality compounder stock; JPM is a large-cap deep-value stock. SBUX, KO, MCD, KDP, JPM pay a dividend while VENU does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.